SCHEMBL9200820

SCHEMBL9200820

O=C1CC(c2cccnc2)C2(c3cccnc3-c3ncccc32)C(c2cccnc2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.40
RAB9A P51151 1/20 0.38
CHRNB2 P17787 5/20 0.36
CHRNA4 P43681 4/20 0.36
CYP11B2 P19099 1/20 0.36
ALDH1A1 P00352 4/20 0.36
CYP3A4 P08684 3/20 0.36
KDM4E B2RXH2 2/20 0.36
THRB P10828 1/20 0.36
TSHR P16473 1/20 0.36
THPO P40225 1/20 0.36
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2C9 P11712 1/20 0.36
CHRNA7 P36544 4/20 0.35
CHRNA3 P32297 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9198802 0.87 NFKB1 (0.45) ALDH1A1THRBMEN1KMT2ANPSR1
SCHEMBL9199038 0.86 NFKB1 (0.35) RAB9ATHRBTSHRMEN1KMT2A
SCHEMBL9545132 0.83 CYP11B2 (0.45) CYP2A6CHRNB2CHRNA4CYP11B2ALDH1A1
SCHEMBL9195303 0.82 CYP2A6 (0.36) CYP2A6THRBMEN1KMT2ACYP1A2
SCHEMBL9545130 0.81 CYP19A1 (0.37) CYP2A6RAB9AALDH1A1KDM4EMEN1
SCHEMBL9545138 0.81 CYP19A1 (0.37) CYP2A6RAB9AALDH1A1KDM4EMEN1
SCHEMBL9545532 0.77 MAPT (0.35) CYP11B2ALDH1A1KDM4EMEN1MAPK1
SCHEMBL9194471 0.77 GSK3B (0.47) RAB9AALDH1A1KMT2ACYP1A2CYP2C19
SCHEMBL26422507 0.70 CYP11B2 (0.58) CYP2A6RAB9ACHRNB2CHRNA4CYP11B2
SCHEMBL9275393 0.68 PDK2 (0.33) CYP11B2ALDH1A1KMT2ANPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636132-A1 SUBSTITUTED NITROGEN CONTAINING SPIRO COMPOUNDS FOR USE IN TREATING COGNITIVE DEFICITS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-02-01 EP disclosed
WO-1993021185-A1 SUBSTITUTED NITROGEN CONTAINING SPIRO COMPOUNDS FOR USE IN TREATING COGNITIVE DEFICITS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-10-28 WO disclosed